围产期胸腹盆腔肿瘤的产前诊断与产后管理:多中心经验
该回顾性多中心研究纳入2010年1月至2021年5月巴黎大区153例产前或生后3个月内诊断的胸腹盆腔实体肿瘤,仅35%产前检出,最常见为神经母细胞瘤(61%),随访中位5年89%存活,预后总体良好。
要点
- 产前仅检出35%的围产期胸腹盆腔肿瘤,其中62%在孕晚期发现。
- 神经母细胞瘤最常见(61%),肾上腺为最主要部位(43%)。
- 产后检出者远处转移比例(36%)高于产前检出者(4%)。
核心结论
- 仅35%的围产期胸腹盆腔肿瘤在出生前被检出;尽管以恶性为主,预后总体良好;提高早期检出可能有助于产后多学科管理和家长指导。
研究设计与样本
- 回顾性多中心研究,纳入2010年1月至2021年5月巴黎大区所有产前或生后3个月内诊断的胸部、腹部或盆腔肿瘤患者,共153例。
诊断标准与关键数值
- 产前检出53/153例(35%),其中62%在孕晚期发现;产后诊断确认中位时间9天(IQR 2-20天)。
- 产后检出100/153例(65%),主要依据肿瘤团块综合征(39%)或父母/常规体检触及肿块(36%),检出中位时间73天(IQR 39-104天)。
- 产前检出者远处转移2/53例(4%),产后检出者远处转移36/100例(36%)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The primary objective was to assess the accuracy of prenatal examination in detecting and characterizing perinatal solid tumors of the thoracoabdominopelvic region. Secondary objectives were to describe the epidemiology, clinical characteristics and outcome of these tumors.
METHODS: This was a retrospective multicenter study of all patients with a thoracic, abdominal or pelvic tumor diagnosed prenatally or within the first 3 months after birth in the Île-de-France area between January 2010 and May 2021. The gestational age at which a mass was detected on prenatal imaging, or the postnatal age at which the first tumor-related sign or symptom was noted, in addition to the timing of postnatal diagnostic confirmation (clinicoradiological or pathological), were extracted from patient medical files.
RESULTS: Overall, 153 tumors were identified. An associated congenital malformation was identified in 14 (9%) infants and four (3%) had a known germline pathogenic variant. The main tumor locations were adrenal gland (43%), extra-adrenal and extrarenal retroperitoneum (12%) and kidney (12%). The most common diagnoses were neuroblastoma (93/153 (61%)) (including 65 adrenal, 20 extra-adrenal retroperitoneal and eight thoracic/mediastinal), hepatoblastoma (10/153 (7%)), teratoma (10/153 (7%)), nephroblastoma (8/153 (5%)) and congenital mesoblastic nephroma (7/153 (5%)). In 35% (53/153) of cases, a mass was detected prenatally (mainly during the third trimester (62%)) and the diagnosis was confirmed at a median of 9 (interquartile range (IQR), 2-20) days after birth. Tumor detection was postnatal in 65% (100/153) of cases, mainly on the basis of tumor mass syndrome (39%) or tumor palpation by parents or during a routine medical visit (36%), and occurred at a median of 73 (IQR, 39-104) days after birth. Distant metastasis was noted in 4% (2/53) of cases with a prenatal mass and in 36% (36/100) of cases detected postnatally. Five medical terminations of pregnancy for a compressive tumor were reported, in addition to one in-utero fetal demise. Five (3%) neonates required early supportive intensive care due to respiratory distress, arterial hypertension, intestinal perforation or intestinal obstruction. At a median follow-up of 5 (range, 0-14) years, 136 (89%) patients remained alive.
CONCLUSIONS: Only 35% of perinatal thoracic, abdominal and pelvic tumors were detected before birth. Although mainly malignant, their prognosis was largely favorable. Improving early detection may assist postnatal multidisciplinary management and parental guidance. © 2025 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Khawand C, Orbach D, Berrebi D, et al. Prenatal diagnosis and postnatal management of perinatal thoracoabdominopelvic tumors: multicenter experience. Ultrasound Obstet Gynecol. 2025. PMID: 40847681. doi:10.1002/uog.70000
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。